Kess Mughelli-Ogden
Psychiatry · Fort Sam Houston, TXNPI 1215223284
Payments from drug & device makers
Across 168 payments — averaging $18.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$676
- Johnson & Johnson$580
- Otsuka America Pharmaceutical, Inc.$393
- Teva Pharmaceuticals USA, Inc.$366
- Indivior Inc.$326
- Lundbeck LLC$209
- plus $495 from 6 others
What the payments were for
- Food & beverage$2,95497%
- Education$913%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 43 | $676 |
| Johnson & Johnson | 32 | $580 |
| Otsuka America Pharmaceutical, Inc. | 21 | $393 |
| Teva Pharmaceuticals USA, Inc. | 18 | $366 |
| Indivior Inc. | 17 | $326 |
| Lundbeck LLC | 11 | $209 |
| Neurocrine Biosciences, Inc. | 10 | $193 |
| Alkermes, Inc. | 10 | $174 |
| Vanda Pharmaceuticals Inc. | 3 | $76 |
| Eisai Inc. | 1 | $20 |
| Ironshore Pharmaceuticals Inc. | 1 | $19 |
| Bausch Health US, LLC | 1 | $13 |
How this compares
$3,046 in reported general payments places this provider in the 80th percentile of 2,238 psychiatry providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 11 | $16,638 |
| Aripiprazole | 15 | $5,871 |
| Haloperidol Decanoate | 11 | $579 |
| Memantine Hcl ErMemantine Hcl | 12 | $563 |
| Haloperidol | 18 | $538 |
| Ziprasidone Hcl | 25 | $420 |
| Divalproex Sodium | 26 | $379 |
| Buspirone Hcl | 31 | $366 |
| Benztropine Mesylate | 27 | $363 |
| Quetiapine Fumarate | 31 | $360 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 27 | $243 |
| Duloxetine Hcl | 11 | $221 |
| Trazodone Hcl | 24 | $209 |
| Olanzapine | 13 | $204 |
| Sertraline Hcl | 14 | $195 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $676 | $16,63811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,238 psychiatry providers in Texas.
Other psychiatry in Fort Sam Houston
- Scott BartleyDallas$42.7M
- David BrownAustin$15.8M
- Rajinder ShiwachDesoto$15.4M
- Darin OkudaDallas$14.7M
- Jason MensahBeaumont$10.3M
- Michael DowningDallas$7.6M
- Rakesh JainLake Jackson$7.2M
- Suresh SureddiPlano$5.9M
- Marshall LucasThe Woodlands$4.8M
- Sejal MehtaPlano$3.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.